Cross border disclaimers

Securities mentioned in this material have not been, and will not be, submitted for approval nor registered with the Securities and Exchange Commission of Brazil (CVM). Documents and information herein are not being used in connection with any offer for subscription or sale to the public in Brazil.

Disclaimers provided by Articles 21 and 22 of CVM Resolution No. 20/2021 apply.

This report is only intended for Brazilian residents who are directly purchasing or selling securities in the Brazil capital market through a local authorized institution.

This is an individual and private offer. This information is confidential and is not to be reproduced or distributed to third parties, as this is NOT a public offering of securities in Costa Rica.

The product being offered is not intended for the Costa Rican public or market and neither is authorized or will be supervised by the General Superintendence of Securities (“SUGEVAL”), nor can be traded in the secondary market. Even if this private offer is required to be reported to the SUGEVAL, pursuant to article 8bis of the Regulations on the Public Offering of Securities (Reglamento sobre Oferta Pública de Valores), such reporting will not constitute an authorization from SUGEVAL nor registration at the National Registry of Securities and Intermediaries; neither it will imply regulation or supervision of the offering under the applicable public offering regime in Costa Rica.

This is an individual and private offer which is made in Costa Rica upon reliance on an exemption from registration before the General Superintendence of Securities (“SUGEVAL”), pursuant to article 6 of the Regulations on the Public Offering of Securities (“Reglamento sobre Oferta Pública de Valores”). This information is confidential, and is not to be reproduced or distributed to third parties, as this is NOT a public offering of securities in Costa Rica.

The product being offered is not intended for the Costa Rican public or market and neither is registered or will be registered before the SUGEVAL, nor can be traded in the secondary market.

This communication and any offering material term sheet, research report, other product or service documentation or any other information (the "Material") sent with this communication was done so as a result of a request received by UBS from you and/or persons entitled to make the request on your behalf. Should you have received the Material erroneously, UBS asks that you kindly delete the e-mail and inform UBS immediately. The Material, where provided, was provided for your information only and is not to be further distributed in whole or in part in or into your jurisdiction without the consent of UBS. The Material may not have been reviewed, approved, disapproved or endorsed by any financial or regulatory authority in your jurisdiction. UBS has not, by virtue of the Material, made available, issued any invitation to subscribe for or to purchase any investment (including securities or products or futures contracts). The Material is neither an offer nor a solicitation to enter into any transaction or contract (including future contracts) nor is it an offer to buy or to sell any securities or products. The relevant investments will be subject to restrictions and obligations on transfer as set forth in the Material, and by receiving the Material you undertake to comply fully with such restrictions and obligations. You should carefully study and ensure that you understand and exercise due care and discretion in considering your investment objective, risk appetite and personal circumstances against the risk of the investment. You are advised to seek independent professional advice in case of doubt.

Any and all advice provided on and/or trades executed by UBS pursuant to the Material will only have been provided upon your specific request or executed upon your specific instructions, as the case may be, and may be deemed as such by UBS and you.

Nothing in this [Private Placement Memorandum] constitutes the making available, or offer for subscription or purchase, or invitation to subscribe for or purchase, or sale, of Interests in the Fund in Malaysia. No approval of, or recognition by, the Securities Commission of Malaysia has been or will be obtained for the making available, offer for subscription or purchase, or invitation to subscribe for or purchase, or sale, of [Interests in the Fund] to any persons in Malaysia. In addition, no approval of the Registrar of Companies in Malaysia has been or will be obtained for the issuance, or offer for subscription or purchase, or invitation to subscribe for or purchase, or sale of [Interests in the Fund] to the public in Malaysia. Accordingly, [Interests in the Fund] will only be made available or offered or sold exclusively to persons outside Malaysia. This [Private Placement Memorandum] or any disclosure document has not and will not be registered or deposited with the Securities Commission of Malaysia, on the basis that the Interests in the Fund will not be made available, offered or sold in Malaysia. This [Private Placement Memorandum] may not be circulated or distributed in Malaysia, whether directly or indirectly, for the purpose of making available, or offer for subscription or purchase, or invitation to subscribe for or purchase, or sale, of [Interests in the Fund] in Malaysia.

The investment products mentioned in this material are not being offered or sold by UBS to the public in Nigeria and they have not been submitted for approval nor registered with the Securities and Exchange Commission of Nigeria (SEC). If you are interested in products of this nature, please let us know.

The investment products mentioned in this material are not being directed to, and are not being made available for subscription by any persons within Nigeria other than the selected investors to whom the offer materials have been addressed as a private sale or domestic concern within the exemption and meaning of Section 69(2) of the Investments and Securities Act, 2007 (ISA).

This material has been provided to you at your specific unsolicited request and for your information only. The investment products mentioned in this material are not being offered or made available for sale by UBS in Nigeria and they have not been submitted for approval nor registered with the Securities and Exchange Commission of Nigeria (SEC).

This communication and any offering material term sheet, research report, other product or service documentation or any other information (the "Material") sent with this communication was done so as a result of a request received by UBS from you and/or persons entitled to make the request on your behalf. Should you have received the Material erroneously, UBS asks that you kindly delete the e-mail and inform UBS immediately. The Material, where provided, was provided for your information only and is not to be further distributed in whole or in part in or into your jurisdiction without the consent of UBS. The Material may not have been reviewed, approved, disapproved, endorsed, registered or filed with any financial or regulatory authority in your jurisdiction. UBS has not, by virtue of the Material, made available, issued any invitation to subscribe for or to purchase any investment (including securities or derivatives products). The Material is neither an offer nor a solicitation to enter into any transaction or contract (including future contracts) nor is it an offer to buy or to sell any securities or derivatives products. The relevant investments will be subject to restrictions and obligations on transfer as set forth in the Material, and by receiving the Material you undertake to comply fully with such restrictions and obligations. You should carefully study and ensure that you understand and exercise due care and discretion in considering your investment objective, risk appetite and personal circumstances against the risk of the investment. You are advised to seek independent professional advice in case of doubt.

Any and all advice provided on and/or trades executed by UBS pursuant to the Material will only have been provided upon your specific request or executed upon your specific instructions, as the case may be, and may be deemed as such by UBS and you.

UBS AG is not licensed to conduct banking and financial activities in Portugal nor is UBS AG supervised by the Portuguese Regulators (Bank of Portugal “Banco de Portugal” and Portuguese Securities Exchange Commission “Comissão do Mercado de Valores Mobiliários”).

This document or information contained therein is for information purposes only and constitutes neither a public nor a private offering, is not an invitation to make offers, to sell, exchange or otherwise transfer any financial instruments in the Russian Federation to or for the benefit of any Russian person or entity and does not constitute an advertisement or offering of securities in the Russian Federation within the meaning of Russian securities laws. The information contained herein is not an “individual investment recommendation” as defined in Federal Law of 22 April 1996 No 39-FZ “On Securities Market” (as amended) and the financial instruments and operations specified herein may not be suitable for your investment profile or your investment goals or expectations. The determination of whether or not such financial instruments and operations are in your interests or are suitable for your investment goals, investment horizon or the acceptable risk level is your responsibility. We assume no liability for any losses connected with making any such operations or investing into any such financial instruments and we do not recommend to use such information as the only source of information for making an investment decision.

UBS employees traveling to Russia are neither authorized to conclude contracts nor to negotiate financial terms thereof while in Russia. Contracts only become binding on UBS once confirmed in the United Kingdom.  UBS employees traveling to Russia are not permitted to provide an investment recommendation. Information on securities or investment products provided within Russia therefore illustrate generic capabilities of UBS or product or asset classes and do not necessarily reflect the risk profile or investment goals of the client, hence such information does not represent advice.

UBS AG

Within UBS Wealth Management, your account relationship will be with UBS AG in the United Kingdom. Name and postal address: UBS AG

5 Broadgate, London EC2M 2QS Tel: +44 207 567 8000Contact UBS AG

www.ubs.comUBS website

In the United Kingdom, UBS AG is authorised by the Prudential Regulation Authority (PRA) and subject to the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of our regulation by the PRA are available from us on request. Further, UBS AG is a licensed Financial Service Provider in terms of the Financial Advisory and Intermediary Services Act ("FAIS" Act), License No. 30475, and is registered as an accountable institution with the Financial Intelligence Centre ("FIC") in South Africa (ID 67683).

Compliance with the Financial Advisory and Intermediary Services Act (“FAIS”)

Compliance with the FAIS Act is monitored by the Compliance officer referenced for UBS AG under the following link: https://www.fsca.co.za/MagicScripts/mgrqispi.dll

Complaints

At UBS AG, we value our clients and endeavor to always achieve the highest possible standards in service. We appreciate that things can sometimes go wrong leading to a possible complaint.

Should you wish to make a complaint, please find below the contact details. A complaints process is in place which can be reviewed upon request.

Client Complaints Contacts

Clients are requested, wherever possible, to submit all complaints in writing to assist UBS AG with resolving the complaint satisfactorily and to ensure proper record keeping in line with the requirements of the South African FAIS Act. All information and supporting documentation relevant to the complaint should be included with the complaint. Any client complaint should be submitted via your Client Advisor.

Should the client wish to pursue their complaint further in South Africa, then a complaint to the FAIS Ombudsman can be submitted (within the space of six months).

The contact details of the South African Ombudsman can be found on the following website:

Website: www.faisombud.co.zaWebsite of South African Ombudsman

E-mail Address: info@faisombud.co.zaEmail address of South African Ombudsman

UBS AG holds professional indemnity and fidelity insurance cover in accordance with the FAIS Act and related regulations.

Product suppliers

UBS holds a number of contracts with product suppliers as per the product supplier list published on: https://www.ubs.com/za/en.htmlProduct supplier list

Additional information

In addition to the above, please take note of the UBS Terms and Conditions and general disclosure and information provided to you as part of the account opening documentation and any additional product/service agreements, as the case may be. For further information please contact your client advisor or refer to the UBS website: www.ubs.comUBS website.

The information in this document is not provided for the purpose of offering, marketing or sale of any capital market instrument or service in the Republic of Türkiye. Therefore, this document may not be considered as an offer made, or to be made, to residents of the Republic of Türkiye in the Republic of Türkiye. UBS AG is not licensed by the Turkish Capital Market Board (the CMB) under the provisions of the Capital Market Law (Law No. 6362). Accordingly, neither this document nor any other offering material related to the instrument/service may be utilized in connection with providing any capital market services to persons within the Republic of Türkiye without the prior approval of the CMB. However, according to article 15 (d) (ii) of the Decree No. 32 residents of the Republic of Türkiye are allowed to purchase or sell the financial instruments traded in financial markets outside of the Republic of Türkiye. Further to this, pursuant to article 9 of the Communiqué on Principles Regarding Investment Services, Activities and Ancillary Services No. III-37.1, investment services provided abroad to residents of the Republic of Türkiye based on their own initiative are not restricted.

UBS is not a financial institution licensed in the UAE by the Central Bank of the UAE nor by the Emirates’ Securities and Commodities Authority and does not undertake banking activities in the UAE. UBS AG Dubai Branch is licensed by the DFSA in the DIFC.

Required for any written material (sufficient if in signature field)

UBS is not a financial institution licensed in the UAE by the Central Bank of the UAE nor by the Emirates’ Securities and Commodities Authority and does not undertake banking activities in the UAE. UBS AG Dubai Branch is licensed by the DFSA in the DIFC.

For instrument specific research the following language or equivalent wording has to be added

This document is provided for your information only and does not constitute financial advice.

Required if a client asks for Sharia’h friendly products

UBS does not carry out any Financial Service in accordance with the Sharia’h. It is the client’s obligation to seek information and take a view on whether and to which degree a product may be in accordance with the principles of the Sharia’h

Required if a client asks for Sharia’h compliant products

UBS does not carry out any Financial Service in accordance with the Sharia’h. Any information or advice provided does not extend to whether or not and to which degree a product may be in accordance with the principles of the Sharia’h. It is the client’s obligation to seek information and take a view on whether and to which extent a product is in accordance with the principles of the Sharia’h. A product provider may have a Sharia’h Board representing scholar views to attest to the Sharia’h compliant nature of a product. UBS will forward such information to the client on request. Such information however does not represent any view by UBS and UBS does not take responsibility for the correctness or appropriateness of the information provided. It is the client’s obligation alone to determine as to whether or not and to which extent to place reliance on such information.

UBS is a premier global financial services firm offering wealth management services to individual, corporate and institutional investors. UBS is established in Switzerland and operates under Swiss law and in over 50 countries and from all major financial centers. UBS is not registered and licensed as a bank/financial institution under Ukrainian legislation and does not provide banking and other financial services in Ukraine. UBS has not made, and will not make, any offer of the mentioned products to the public in Ukraine. No action has been taken to authorize an offer of the mentioned products to the public in Ukraine and the distribution of this document shall not constitute financial services for the purposes of the Law of Ukraine "On Financial Services and Financial Companies" dated 14 December 2021. Any offer of the mentioned products shall not constitute investment advice, a public offer, circulation, transfer, safekeeping, holding or custody of securities in the territory of Ukraine. Accordingly, nothing in this document or any other document, information or communication related to the mentioned products shall be interpreted as containing an offer, a public offer or invitation to offer or to a public offer, or solicitation of securities in the territory of Ukraine or investment advice under Ukrainian law. Electronic communication must not be considered as an offer to enter into an electronic agreement or other electronic instrument ("електронний правочин") within the meaning of the Law of Ukraine "On Electronic Commerce" dated 3 September 2015. This document is strictly for private use by its holder and may not be passed on to third parties or otherwise publicly distributed.

UBS AG London Branch is not an SEC-registered broker-dealer or investment adviser in the United States. As such, the material presented is not directed at, or intended for distribution to or use by, any person or entity who is a US citizen or resident located or incorporated in the United States or otherwise deemed a US Person under applicable law. The services, securities, and financial instruments presented may not be available and/or are not offered in the United States and accordingly, the rules for the protection of private customers that apply in the United States will not apply in relation to such products and services.